Core Viewpoint - The article discusses the performance of the Zhongzheng 1000 ETF Enhanced (561280), highlighting its recent market movements and key holdings [1]. Group 1: Fund Performance - The Zhongzheng 1000 ETF Enhanced (561280) opened with a gain of 0.56%, priced at 1.443 yuan [1]. - Since its establishment on August 31, 2023, the fund has achieved a return of 42.77%, while its return over the past month has been -4.93% [1]. Group 2: Key Holdings - Major stocks in the fund include: - Boqian New Materials, up 0.68% - Haoyuan Pharmaceutical, up 0.88% - Yingjixin, up 1.01% - Caixun Co., up 0.51% - Jinma Amusement, up 1.22% - Panjiang Co., up 0.42% - Jindawei, up 1.02% - Yiyuan Communication, up 0.69% - Minxin Co., up 0.50% - Nami Technology, up 0.48% [1].

Core Viewpoint - Nanwei Technology experienced a decline of 5.92% on November 21, with a trading volume of 157 million yuan, indicating potential market volatility and investor sentiment concerns [1] Financing Summary - On November 21, Nanwei Technology had a financing buy-in amount of 19.78 million yuan and a financing repayment of 26.99 million yuan, resulting in a net financing outflow of 7.21 million yuan [1] - As of November 21, the total financing and securities lending balance for Nanwei Technology was 385 million yuan, with the current financing balance at 383 million yuan, accounting for 3.55% of the circulating market value, which is above the 90th percentile level over the past year [1] - The company repaid 1,900 shares in securities lending and sold 2,000 shares on the same day, with a selling amount of 53,400 yuan, while the securities lending balance was 1.49 million yuan, also exceeding the 90th percentile level over the past year [1] Company Overview - Nanwei Technology, established on October 22, 2007, and listed on June 23, 2021, specializes in the research, large-scale production, sales, and application services of high-performance nano-microsphere materials [2] - The company's main business revenue composition includes: chromatography fillers and chromatography media products (57.62%), chromatography analysis instruments and accessories (19.72%), liquid chromatography columns and sample pretreatment products (10.44%), protein chromatography systems and accessories (5.02%), microsphere products for optoelectronics (3.98%), and others [2] - As of September 30, the number of shareholders for Nanwei Technology was 16,100, an increase of 6.57% from the previous period, with an average of 25,091 circulating shares per person, a decrease of 6.16% [2] Financial Performance - For the period from January to September 2025, Nanwei Technology achieved an operating income of 671 million yuan, representing a year-on-year growth of 22.01%, and a net profit attributable to the parent company of 108 million yuan, reflecting a significant year-on-year increase of 156.56% [2] Dividend Information - Since its A-share listing, Nanwei Technology has distributed a total of 115 million yuan in dividends, with 86.84 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, among the top ten circulating shareholders of Nanwei Technology, the China Europe Medical Health Mixed A Fund (003095) ranked as the tenth largest shareholder, holding 6.93 million shares, a decrease of 1.26 million shares from the previous period [3]

Core Insights - Suzhou Industrial Park is leveraging ESG (Environmental, Social, and Governance) principles to drive sustainable economic growth and ecological balance, achieving significant reductions in energy consumption and carbon emissions compared to national averages [1][3][11] Policy and Standards - The park has established a comprehensive ESG framework, integrating policy guidance and innovative standards to enhance local enterprises' competitiveness and sustainability [3][4] - A set of policies, including the "ESG Industry Development Action Plan," has been implemented to create a management loop from objectives to execution, with financial incentives and innovative standards playing crucial roles [3][4] ESG Industry Development - By 2025, the ESG industry in the park is projected to exceed 65 billion yuan, with over 200 green manufacturing enterprises nurtured [4] - The park has developed an ESG evaluation standard that aligns with international benchmarks, filling a gap in domestic ESG assessment for development zones [3][4] Financial Support and Innovation - A multi-layered financial support system is being established, including innovative green financial products that link loan rates to ESG performance, thereby incentivizing sustainable practices among enterprises [8] - The ESG Industry Innovation Center has provided customized services to over 500 enterprises, enhancing their ESG capabilities and facilitating their transition to sustainable operations [7][8] International Collaboration and Recognition - The park is actively engaging in international ESG standard-setting and sharing its experiences, positioning itself as a model for other regions [9][10] - It has received recognition for its green practices, being included in various international sustainability reports and initiatives [11] Future Outlook - The park aims to transition from policy-driven to market-driven ESG practices by 2030, with plans to double the number of ESG enterprises and industry scale compared to 2025 [11]

Core Insights - Suzhou Industrial Park is leveraging ESG (Environmental, Social, and Governance) principles to drive sustainable economic growth and ecological balance, achieving significant reductions in energy consumption and carbon emissions compared to national averages [1][11] - The park has established a comprehensive ESG framework that includes policy support, standardization, and financial incentives, positioning itself as a national benchmark for ESG practices [3][4] Group 1: ESG Implementation and Impact - The park's ESG initiatives have led to the establishment of a "310 industrial system," integrating ESG as an independent industry that collaborates with key sectors like biomedicine and nanotechnology [5] - By 2024, the park aims to generate nearly 900 billion yuan in output from new energy and green industries, with a target of 650 billion yuan in ESG industry scale by the end of 2025 [1][4][10] - The ESG Innovation Center has provided customized services to over 500 enterprises, enhancing their ESG capabilities and facilitating a shift from passive compliance to proactive innovation [6][7] Group 2: Policy and Financial Support - The park has introduced a "policy combination" to promote ESG development, including financial incentives and innovative standards that align with international benchmarks [3][4] - A sustainable development loan program links interest rates to ESG performance, encouraging companies to improve their environmental impact while reducing financing costs [7] - By 2024, the park's green finance initiatives are expected to exceed 80 billion yuan, providing substantial funding for corporate transitions to sustainable practices [7] Group 3: International Collaboration and Recognition - Suzhou Industrial Park is actively engaging in international ESG standardization efforts, collaborating with organizations like the United Nations Environment Programme to share best practices [8][9] - The park's ESG practices have been recognized globally, being featured in the "ESG Standardization Blue Book" and awarded by the United Nations for sustainable development [9][10] - The park's model is being replicated in other regions, enhancing the overall quality of development in the Yangtze River Delta [9]

Core Viewpoint - The research led by Zhang Yiheng's team at the Tianjin Institute of Industrial Biotechnology has achieved a breakthrough in converting cellulose into starch with a conversion rate of 93.3%, significantly improving the previous theoretical limit of 50% and addressing food security issues in China [4][11][12]. Group 1: Food Security Challenges - China faces a food security dilemma with 1.58 billion tons of imported grain in 2024, including 26.4 million tons of starch-based grains and approximately 100 million tons of soybeans, while 600 million tons of straw are wasted annually [9][10]. - The annual production of terrestrial plants generates about 2 billion tons of lignocellulose, which is 26 times the current grain production, indicating a potential to create a new agricultural scale by utilizing just 4% of this resource [10]. Group 2: Technological Breakthroughs - The new "multi-enzyme molecular machine" technology allows for the conversion of cellulose to starch with a theoretical yield of nearly 100%, overcoming the limitations of traditional microbial metabolism [4][11]. - The innovative design includes a "recycling system" for glucose, which was previously wasted, and employs a seven-enzyme system to achieve the conversion [11][12]. Group 3: Industrial Applications - The first application target is in the chiral drug separation market, where the newly synthesized starch can meet high precision separation needs, previously dominated by Japanese companies [14][19]. - The team has established a collaboration with Suzhou Nano Micro Technology to utilize their expertise in surface modification, enhancing the performance of the new starch for drug separation [14][19]. Group 4: Commercialization Strategy - Zhang Yiheng emphasizes the importance of aligning technology with market needs, introducing the concept of "PC value" (Product Cost ratio) to guide the commercialization of biomanufactured products [15][18]. - The strategy includes a three-step approach to maximize the value of lignocellulosic resources, starting with the extraction of hemicellulose for high-value products before processing cellulose into starch [17][18]. Group 5: Future Directions - The team aims to reduce enzyme costs and scale up the production process while exploring applications in plant-based capsules and biodegradable materials [18][19]. - Zhang Yiheng's vision includes transforming agricultural waste into valuable food sources, contributing to China's food security and economic growth [18][22].

Market Overview - The chemical pharmaceutical sector experienced a decline of 1.44% on November 19, with Hainan Haiyao leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Shanhe Pharmaceutical (300452) with a closing price of 15.07, up 9.04% and a trading volume of 390,200 shares, totaling 586 million yuan [1] - ST Suhao (600200) closed at 1.02, up 5.15% with a trading volume of 429,200 shares [1] - ST Jingfeng (000908) closed at 66.8, up 5.02% with a trading volume of 354,800 shares [1] - Major decliners included: - Muan Nanhai (000566) with a closing price of 7.20, down 10.00% and a trading volume of 2,192,500 shares, totaling 1.625 billion yuan [2] - Sitaili (603520) closed at 10.66, down 6.74% with a trading volume of 315,600 shares [2] - Yatai Pharmaceutical (002370) closed at 7.79, down 6.59% with a trading volume of 1,044,700 shares [2] Capital Flow - The chemical pharmaceutical sector saw a net outflow of 2.278 billion yuan from institutional investors, while retail investors contributed a net inflow of 2.139 billion yuan [2] - The top stocks by net inflow from institutional investors included: - Changshan Pharmaceutical (300255) with a net inflow of 71.90 million yuan, accounting for 6.20% of total inflow [3] - Xingqi Eye Medicine (300573) with a net inflow of 70.33 million yuan, representing 12.29% [3] - Shanhe Pharmaceutical (300452) with a net inflow of 68.13 million yuan, making up 11.62% [3]

证券代码：688690 证券简称：纳微科技 公告编号：2025-039 苏州纳微科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 2、 公司在任监事3人，出席3人； （一） 股东大会召开的时间：2025 年 11 月 17 日 （二） 股东大会召开的地点：江苏省苏州市工业园区百川街 2 号研发中心大楼 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 74 | | --- | --- | | 普通股股东人数 | 74 | | 2、出席会议的股东所持有的表决权数量 | 176,061,462 | | 普通股股东所持有表决权数量 | 176,061,462 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 43.9332 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量 ...

北京市中伦（上海）律师事务所 关于苏州纳微科技股份有限公司 2025 年第一次临时股东大会 法律意见书 二〇二五年十一月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 法律意见书 北京市中伦（上海）律师事务所 关于苏州纳微科技股份有限公司 2025 年第一次临时股东大会 法律意见书 致苏州纳微科技股份有限公司： 北京市中伦（上海）律师事务所（以下简称"本所"）作为苏州纳微科技股 份有限公司（以下简称"公司"）的法律顾问，受公司委托，指派律师出席公司 2025 年第一次临时股东大会（以下简称"本次股东 ...

Group 1 - The core business of Nanwei Technology involves the research, large-scale production, sales, and application services of high-performance nano microsphere materials, serving clients in biomedicine, flat panel displays, analytical testing, and in vitro diagnostics [2] - As of September 30, 2025, Nanwei Technology achieved operating revenue of 671 million yuan, representing a year-on-year growth of 22.01%, and a net profit attributable to shareholders of 108 million yuan, with a significant year-on-year increase of 156.56% [2] - The company has distributed a total of 115 million yuan in dividends since its A-share listing, with 86.84 million yuan distributed over the past three years [3] Group 2 - On November 14, Nanwei Technology's stock price fell by 1.02%, with a trading volume of 142 million yuan [1] - The financing buy-in amount for Nanwei Technology on November 14 was 22.54 million yuan, while the financing repayment was 21.62 million yuan, resulting in a net financing buy-in of 918,600 yuan [1] - The total balance of margin trading for Nanwei Technology as of November 14 was 363 million yuan, with the financing balance accounting for 2.98% of the circulating market value, indicating a high level compared to the past year [1]

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 股东大会有关情况 证券代码：688690 证券简称：纳微科技 公告编号：2025-038 苏州纳微科技股份有限公司 关于2025年第一次临时股东大会 取消部分议案的公告 近日，公司在对候选人关联关系进行补充核查时发现，按照公司相关管理制 1、 股东大会的类型和届次： 2025年第一次临时股东大会 2、 股东大会召开日期：2025 年 11 月 17 日 3、 股东大会股权登记日： | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | A 股 | 688690 | 纳微科技 | 2025/11/11 | 二、 取消议案的情况说明 1、 取消议案名称 | 序号 | 议案名称 | | --- | --- | | 3 | 关于补选董事的议案 | 2、 取消议案原因 公司于 2025 年 10 月 27 日召开第三届董事会第九次会议，审议通过《关于 补选董事的议案》，同意提名刘军博士为公司第三届董事会董事候选人。 度， ...